Results also show eagerness to learn more
New phase 2 data boost hopes for phase 3 Lp(a) HORIZON trial
Intermittent statin dosing & bempedoic acid refresh the mix of options
Cardiac manifestations of this autoimmune disorder can be hidden but deadly
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Multidisciplinary collaboration enables first such operation in a patient with MYH9 mutation
Hazen group to pursue research programs in atherosclerosis, thrombosis, obesity
A sampling of outcome and volume data from our Heart & Vascular Institute
Expert analysis argues that study design may have disadvantaged CABG
With 5-year results now in, a lead investigator looks ahead
An expert reflects on technical advances and rising success rates
Advertisement
Advertisement